AIM Vaccine Co., Ltd.

AIM Vaccine Co., Ltd.verified

6660.HK

Price:

$3.42

Market Cap:

$3.80B

AIM Vaccine Co., Ltd. engages in the research and development, manufacturing, and commercialization of vaccine products for human use in the People's Republic of China. The company's product pipeline includes Bivalent Delta-Omicron BA.5 mRNA and Monovalent Omicron BA.5 mRNA, which is in phase III clinical trails for the treatment of COVID-19; EV71-CA16 Bivalent for HFMD; and Valent Pneumococcal Conjugate and Polysaccharide vaccine for pneumococcal disease. It also offers Hexavalent group B Streptococcus Polysaccharide Conjugate Vaccine for Group B strep disease; Diphtheria, Tetanus and Pertussis and Haemophilus In¬uenzae type B, and Diphtheria, Tetanus and Acellular Pertussis, and Absorbed T...[Read more]

Industry

Biotechnology

IPO Date

2022-10-06

Stock Exchange

HKSE

Ticker

6660.HK

The Enterprise Value as of December 2025 (TTM) for AIM Vaccine Co., Ltd. (6660.HK) is 5.29B

According to AIM Vaccine Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.29B. This represents a change of -34.98% compared to the average of 8.14B of the last 4 quarters.

AIM Vaccine Co., Ltd. (6660.HK) Historical Enterprise Value (quarterly & annually)

How has 6660.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of AIM Vaccine Co., Ltd. over the last ten years is 12.90B. The current 5.29B Enterprise Value has changed 4.00% with respect to the historical average. Over the past ten years (40 quarters), 6660.HK's Enterprise Value was at its highest in in the June 2023 quarter at 50.56B. The Enterprise Value was at its lowest in in the December 2020 quarter at -867793000.00.

Quarterly (TTM)
Annual

Average

12.90B

Median

11.85B

Minimum

8.30B

Maximum

22.43B

AIM Vaccine Co., Ltd. (6660.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AIM Vaccine Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 71.76%

Maximum Annual Enterprise Value = 22.43B

Minimum Annual Increase = -55.80%

Minimum Annual Enterprise Value = 8.30B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20248.30B-16.30%
20239.91B-55.80%
202222.43B71.76%
202113.06B16.45%
202011.21B-10.15%

AIM Vaccine Co., Ltd. (6660.HK) Average Enterprise Value

How has 6660.HK Enterprise Value performed in the past?

The current Enterprise Value of AIM Vaccine Co., Ltd. (6660.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

13.55B

5-year avg

12.98B

10-year avg

12.90B

AIM Vaccine Co., Ltd. (6660.HK) Enterprise Value vs. Peers

How is 6660.HK’s Enterprise Value compared to its peers?

AIM Vaccine Co., Ltd.’s Enterprise Value is greater than Qyuns Therapeutics Co., Ltd. (4.22B), greater than Jiangsu Recbio Technology Co., Ltd. (3.12B), greater than Viva Biotech Holdings (4.08B), less than Medtide Inc. (0), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (2.05B), greater than VISEN Pharmaceuticals (2.78B), greater than Antengene Corporation Limited (1.85B), greater than Jacobio Pharmaceuticals Group Co., Ltd. (4.89B), greater than Peijia Medical Limited (3.22B), greater than Modern Dental Group Limited (5.16B),

Build a custom stock screener for AIM Vaccine Co., Ltd. (6660.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AIM Vaccine Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AIM Vaccine Co., Ltd. (6660.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AIM Vaccine Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is AIM Vaccine Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for AIM Vaccine Co., Ltd. (6660.HK)?

What is the 3-year average Enterprise Value for AIM Vaccine Co., Ltd. (6660.HK)?

What is the 5-year average Enterprise Value for AIM Vaccine Co., Ltd. (6660.HK)?

How does the current Enterprise Value for AIM Vaccine Co., Ltd. (6660.HK) compare to its historical average?